To the Editor: TMPRSS6 is a transmembrane serine protease expressed mainly in the liver that plays an important role during erythropoiesis. TMPRSS6 loss-of-function mutations result in the over-expression of hepcidin, impaired intestinal iron absorption and ironrefractory iron deficiency anemia (IRIDA). Tmprss6 deletion has been shown to improve iron overload and anemia in murine models of beta-thalassemia intermedia, and the siRNA-or antisense oligonucleotide-mediated suppression of Tmprss6 mRNA expression has been demonstrated to increase the hepcidin level, leading to diminished iron uptake and recycling as well as improved erythropoiesis and anemia in beta thalassemic animals [1,2].TMPRSS6 polymorphisms have been implicated in iron metabolism in both animal and human studies. The common rs855791 polymorphism (NM_153609.3:c.2207C>T) causes a nonsynonymous valine to alanine change (p.V736A), and the T allele (encoding valine) has been associated with lower hemoglobin and ferritin concentrations as well as increased serum transferrin receptor and transferrin concentrations in all populations [3]. Moreover, this polymorphism influences iron overload in hereditary hemochromatosis as well as the development of nonalcoholic fatty liver disease [4,5] and it has been associated with iron deficiency anemia in women of reproductive ages [6].The mechanism of action of TMPRSS6 is still unclear. Some studies have indicated that TMPRSS6 polymorphisms directly affect hepcidin transcription, while others have suggested that the polymorphisms may addictionally influence iron homeostasis by mechanisms independent of hepcidin expression. The latter theory could explain why rs855791 has not been found to be significantly associated with serum hepcidin in some studies [3].In this study, we evaluated the influence of rs855791 on liver iron concentration (LIC) in patients with different levels of ineffective erythropoiesis: mild and severe thalassemia intermedia (TI) and Hemoglobin H (HbH) disease patients, which are clinically distinct forms of the so-called nontransfusion-dependent thalassemias (NTDTs), a term used to label patients who do not require regular transfusion for survival. We classified TI in agreement with the extent of imbalance between the alpha and non alpha globin chains. Accordingly, it was considered as mild in case of coinheritance of heterozygous beta thalassemia and, respectively, triple or quadruple alpha globin gene arrangement, delta/beta 0 thalassemia, and mild or silent beta mutation. It was considered as severe in case of homozygosity or compound heterozygosity for beta 0 mutations.In patients with NTDTs, the increased intestinal absorption of iron caused by ineffective erythropoiesis is the main cause of iron overload, which can become clinically relevant by the age of 10 years. Iron overload is associated with liver dysfunction and vascular, bone, and endocrine morbidities and is therefore an important challenge in terms of diagnosis, monitoring, and treatment. Moreover, although much more rarely tha...